USPTO serial 79050353
FRESENIUS KABI
Reviewed by CopyMark Law Group
Reg. 3767516Status 706Registered
- Filing date
- Status date
- Registration date
- Mar 30, 2010
- Examiner
- CHISOLM, KEVON
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with FRESENIUS KABI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
61352 Bad Homburg, DE
61352 Bad Homburg, DE
Bad Homburg, DE
60323 Frankfurt, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St., NWSuite 400WASHINGTON, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, [ enteral and ] parenteral nutrition, [, namely, dietetic products for enteral feeding and nutrition ] for parenteral feeding; admixtures to parenteral nutrition, namely, nutrition admixtures for parenteral nutrition and compounded parenteral nutrition admixtures for parenteral nutrition; Intravenous parenteral nutritional compounds to treat or prevent malnutrition, undernutrition covering the needs of a patient either completely or partly; pharmaceutical preparations, namely, constituents of individual compounded pharmaceutical preparations for use in cancer therapy, infectious diseases, immune therapy, anesthesia and pain therapy as well as critical care therapies requiring individual dosing; [ Pharmaceutical preparations, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; ] Standard infusion solutions for [ fluid, electrolyte and energy supply for reconstitution and ] delivery of drugs and pharmaceutical preparations; infusion solutions for blood volume replacement and treatment of hypovolemia; pharmaceutical preparations, namely, medicated rinsing solutions for washing purposes, blood volume expanders, anti-infectives, analgesics and anesthetics; injectable critical care drugs, namely, parenterally administered pharmaceutical preparations for the therapy of critically ill states, [, namely, for the treatment of cardiovascular conditions, for use as diuretics, ] immune therapies, anticoagulants, [ cerebrovascular therapies, gastrointestinal therapies and hormone therapies; injectable critical care and peri-operative pharmaceuticals for the treatment of allergic reactions; intravenous drugs for infusion therapy, namely, intravenous drugs in the nature of ] intravenous critical care and peri-operative fluids used for [ rehydration, nutrition, electrolyte replenishment and the delivery of pharmaceutical preparations, intravenous critical care and peri-operative formulations used for ] artificial plasma volume maintenance, replacement and expansion; [ Oral drugs, namely, anti-infectives, analgesics and anesthetics; ] pharmaceutical preparations for the treatment of chronic kidney disease; pharmaceutical preparations used in oncology; urology irrigation solutions; sanitary preparations for medical purposes; [ dietetic substances adapted for medical use, namely, food for medically restricted diets, food for diabetics; food supplements, meal replacement drinks; meal replacement powders; nutritional supplements in pediatrics; disinfectants for sanitary purposes; disinfectants for the skin; ] medical packaging sets comprising bags, bottles, structural parts and replacement parts filled with pharmaceutical preparations [ or dietetic products for enteral ] and parenteral nutrition; clinical medical solutions for processing human blood for use in blood transfusions stored in bags; blood processing disposables, namely, processing solutions for storage and washing; blood bank accessories, namely, processing solutions for storage and washing | ACTIVE | — |
| 010 | [ Surgical and medical instruments and apparatus, namely, enteral feeding tubes, enteral feeding pumps, enteral giving sets for administration of enteral feeding; ] Programmable medical devices for global and interactive management of mono- and multi-channel infusion; infusion medical device, namely, medical machine for capturing and processing infusion data; Infusion data monitors, namely, a multi-channel infusion monitor for critical care for analyzing, programming and monitoring infusion information; infusion monitoring sensors and alarms; appliances and instruments comprising the above devices, namely, syringe pumps, volumetric pumps, disposable bags, bottles, pumps and tubes; infusion apparatus racks for concentration of the main supply, infusion configuration and maintenance; Surgical and medical apparatus and instruments, namely, infusion sets and infusion and injection devices for administering drugs; surgical and medical instruments and apparatus ", namely," transfusion apparatus; Surgical and medical apparatus and instruments, namely, medicinal measurement medical instruments as well as parts of the aforementioned goods to measure medicine dosage, hydration, nutrition, blood volume, physiological and cardiovascular parameters and parts and fitting thereof; medical diagnostic apparatus, analytical apparatus for medical purposes and blood volume measuring apparatus; Medical accessories used as parts of infusion apparatus, namely, clamps, connectors, syringes, joints for syringes, adapters, bags, cannulas, catheters, needles; Surgical and medical apparatus and instruments, namely, connectors for infusion sets and cannulas and tubes for infusion systems; Surgical and medical apparatus and instruments, namely, implantable subcutaneous catheters with infusion chamber; medical device, namely, cannulae for continuous drug application subcutaneous; medical accessories, namely, cannulas for port puncturing and implantable pumps; surgical and medical instruments and apparatus, namely, introducer sets used in connection with the implantation of port systems, namely, introducer instruments; infusion pumps and feeding tubes to administer parenteral drugs and parenteral nutrition solutions and parts therefore, namely, clamps, connectors, syringes, joints for syringes, adapters, bags, cannulas, catheters, needles; medical and surgical equipment and disposables used in pharmaceutical compounding of parenteral nutrition and intravenous drugs, namely, medical packaging combinations comprising medical bags and bottles sold empty and parts therefor; medical packaging systems comprising medical bags and bottles as well as their parts and accessories; safety catheters; Surgical and medical apparatus and instruments, namely, automatic blood and blood component processing system for diagnostic medical use; surgical and medical apparatus and instruments, namely, blood collection, mixing and weighing system for surgical and medical use; surgical and medical apparatus and instruments, namely, donation and apheresis couches; surgical and medical apparatus and instruments, namely, docking system for sterile PVC connections and their disposables; surgical and medical instruments and apparatus, namely, seals for medical tubes; surgical and medical instruments and apparatus, namely, tube sealing system with portable sealer with high capacity battery; blood processing equipment, for medical and surgical use, namely, whole blood cooling, transport and storage containers; haemoglobin screening technology, namely, devices for measuring haemoglobin out of human whole blood and its disposables, namely, cuvettes for single use; blood Processing Equipment, namely, automatic system for platelet concentrates agitation for medical and surgical use; blood processing disposables, namely, blood bag systems for collection and processing of whole blood, umbilical cord blood for medical and surgical use; blood processing disposables, namely, transfer bag systems for processing and administration of blood components for medical and surgical use; blood processing disposables, namely, whole blood and Red cell concentrate in-line filtration for flexible and individual processing; blood processing disposables, namely, conventional filter systems for leukodepletion and reduction of microaggregates from blood components; blood processing disposables, namely, cryopreservation system comprising bags, sealer and parts therefore for medical and surgical use; surgical and medical instruments and apparatus, namely, blood cell separator; apheresis system, namely, separation chamber; surgical and medical apparatus and instruments, namely, autotransfusion device; disposables used in autotransfusion, namely, separation chamber for medical and surgical use | ACTIVE | — |
| 016 | Printed matter, namely, printed charts; printed information cards in the fields of health; printed instructional, educational and teaching materials in the fields of health; printed periodicals in the fields of health; publications, namely, brochures, booklets, and teaching materials in the fields of health; health and medical photographs | ACTIVE | — |
| 041 | Educational services, namely, providing seminars in the fields of nutrition, health and medical treatment; providing continuing medical education courses; training services in the fields of nutrition, health and medical treatment; nutrition and health education information | ACTIVE | — |
| 044 | Medical services; Medical services, namely, pharmaceutical compounding for the development of pharmaceutical preparations and medicines; medical services, namely, compounding of nutrition for parenteral feeding [ ; Medical services, namely, drug conjugation with polymers modifying the pharmackinetic and pharmacodynamic parameters of a drug ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Fresenius SE
- Other trademarks owned by Fresenius SE
- Other trademarks owned by Fresenius SE & Co. KGaA
- Other trademarks owned by Fresenius Kabi AG
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named FRESENIUS KABI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 13, 2022 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 7, 2022 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 7, 2022 | INPC | INVALIDATION PROCESSED | — |
| Aug 15, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 15, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 15, 2020 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Dec 9, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 16, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 30, 2019 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 8, 2018 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 2, 2017 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 2, 2016 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 2, 2016 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 29, 2016 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| May 10, 2016 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| May 9, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 30, 2016 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 30, 2015 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 30, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 23, 2011 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 15, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 15, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 30, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 30, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 12, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 7, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 4, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 2, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 1, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 20, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 20, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 1, 2009 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 5, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2009 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 12, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 15, 2008 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 15, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 15, 2008 | ALIE | ASSIGNED TO LIE | — |
| Sep 29, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 29, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 27, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 27, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 27, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 26, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 20, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |